Medline Inc. (MDLN) Stock

Medline Inc. (MDLN) is a Healthcare stock trading at $38.89 (as of 2026-07-20), with a market capitalization of $32.08B. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Medline Inc. manufactures medical-surgical and related products for hospitals, surgery centers, physician offices, post-acute facilities, and nursing homes in the U.S. and internationally. It operates through two segments: Medline Brand, which procures and makes products across surgical solutions, front line care, and laboratory/diagnostics, and Supply Chain Solutions.

Understand Medline Inc.: how it makes money

Medline manufactures and sells medical-surgical products to hospitals, surgery centers, physician offices, post-acute facilities, and nursing home sites, earning revenue by procuring and manufacturing products through its Medline Brand segment and by supplying products through its Supply Chain Solutions segment.

Medline’s profit model combines in-house procurement and manufacturing of med-surg products (Medline Brand) with product supply for care sites (Supply Chain Solutions), so results depend on how effectively it sources, manufactures, and supplies medical products to these facilities.

Business quality (Weak): Clear two-segment business description, but no segment-level revenue split was provided, so the segment revenue view cannot be quantified here.

Bull case

  • Diverse care-site demand footprint: Medline serves multiple types of healthcare providers and facilities, including hospitals, surgery centers, physician offices, post-acute facilities, and nursing home sites.
  • Two-channel business model: It operates through Medline Brand (procures and manufactures products across surgical solutions, front line care, and laboratory and diagnostics) and Supply Chain Solutions (supply to care sites), which can support flexibility in how products reach customers.

Bear case

  • Execution and supply chain sensitivity: Because Medline both procures and manufactures products and also supplies products to care sites, disruptions or cost pressures in procurement, manufacturing, and supply operations can affect profitability.
  • Competitive and pricing pressure risk: As a supplier of medical-surgical and related products to many healthcare facility types, Medline may face competition that can pressure product pricing and mix.
Valuation — source: SEC EDGAR (first-party)
Price$38.89
Market Cap$32.08B
Price / Book1.66
FCF Yield2.8%
DCF Value (model)$16.72
DCF Upside vs Price-57.0%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$28.43B
Net Margin4.1%
Revenue Growth (YoY)10.7%
FCF Growth (YoY)-45.9%
Financial Health — source: SEC EDGAR
Altman Z-Score2.17 (grey)
Valuation vs Sector & Industry
Sector P/E (Healthcare)21.1
Industry P/E (Medical Equipment)30.6
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderCarlyle Group Inc. ($8.33B)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEOJames Boyle
Employees43,000
CountryUS
IPO Date2025-12-17

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Boston Scientific Corporation (BSX)
  • Becton, Dickinson and Company (BDX)
  • DexCom, Inc. (DXCM)
  • ResMed Inc. (RMD)
  • West Pharmaceutical Services, Inc. (WST)
  • Modular Medical, Inc. (MODD)
  • Solventum Corporation (SOLV)
  • Penumbra, Inc. (PEN)
MDLN earnings history · MDLN institutional & insider holders · MDLN KPIs & operating metrics · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-07-20.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.